Skip to main content

Table 7 TreeBagger model to separate stage I lung adenocarcinoma from those with non-inflammatory benign lung disease on 21 samples for validation

From: Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

Signature vs. Benign

Specificity

0.67

Benign

4

2

Predicted

Sensitivity

0.93

Tumor

1

14

outcome

PPV

0.88

 

True outcome

 

NPV

0.80

    

Accuracy

0.86

    
  1. Benign: the samples with non-inflammatory conditions: LAC Stage 1, PPV Positive predictive value, NPV Negative predictive value
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us